Arch Therapeutics to Present at the H.C. Wainwright BioConnect Conference, January 11 – 14, 2021 FRAMINGHAM, Mass., Jan. 05, 2021 — Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, announced today that it will be presenting at the H.C. Wainwright BioConnect Conference, which will be held January 11-14, 2021. Chief Executive Officer, Terrence W. Norchi, MD, and Chief Financial Officer, Richard Davis, are scheduled to present via webcast, which will be available on-demand as of 6:00 AM ET, Monday, Jan. 11, 2021. Conference attendees may request meetings with management here: https://hcwevents.com/bioconnect/. After the event, the presentation will be available here: https://ir.archtherapeutics.com/presentations.